Immunofluorescence results demonstrated that treatment of tumors with S.t-ΔpGlux/pT-ClyA resulted in a significant increase in tumor infiltration by macrophages (CD68), dendritic cells (CD11c), and neutrophils (Ly-6G/Ly-6C). The gene discussed is ITGAX; the disease is neoplasm.